INS and type 2 diabetes mellitus: In skeletal muscle, insulin inhibits proteolysis [31] and increases the preference for BCAA oxidation [13], which may explain the blunted excursion of BCAA and BCKA metabolites in insulin-resistant individuals with type 2 diabetes as compared with NGT.